- Home
- LMFA vs SONN Comparison
LMFA vs SONN Comparison
Compare LMFA & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMFA
- SONN
- Stock Information
- Founded
- LMFA 2008
- SONN N/A
- Country
- LMFA United States
- SONN United States
- Employees
- LMFA N/A
- SONN N/A
- Industry
- LMFA Finance: Consumer Services
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- LMFA Finance
- SONN Health Care
- Exchange
- LMFA Nasdaq
- SONN Nasdaq
- Market Cap
- LMFA 18.9M
- SONN 21.4M
- IPO Year
- LMFA 2015
- SONN N/A
- Fundamental
- Price
- LMFA $1.00
- SONN $4.75
- Analyst Decision
- LMFA Strong Buy
- SONN Strong Buy
- Analyst Count
- LMFA 1
- SONN 1
- Target Price
- LMFA $5.00
- SONN $20.00
- AVG Volume (30 Days)
- LMFA 659.9K
- SONN 502.2K
- Earning Date
- LMFA 11-14-2025
- SONN 12-16-2025
- Dividend Yield
- LMFA N/A
- SONN N/A
- EPS Growth
- LMFA N/A
- SONN N/A
- EPS
- LMFA N/A
- SONN N/A
- Revenue
- LMFA $6,755,925.00
- SONN $1,000,000.00
- Revenue This Year
- LMFA N/A
- SONN $5,376.22
- Revenue Next Year
- LMFA $15.59
- SONN N/A
- P/E Ratio
- LMFA N/A
- SONN N/A
- Revenue Growth
- LMFA N/A
- SONN 1689.52
- 52 Week Low
- LMFA $0.89
- SONN $1.08
- 52 Week High
- LMFA $5.14
- SONN $19.30
- Technical
- Relative Strength Index (RSI)
- LMFA 38.93
- SONN 50.93
- Support Level
- LMFA $1.01
- SONN $3.52
- Resistance Level
- LMFA $1.15
- SONN $5.85
- Average True Range (ATR)
- LMFA 0.10
- SONN 0.56
- MACD
- LMFA -0.01
- SONN 0.08
- Stochastic Oscillator
- LMFA 24.25
- SONN 53.58
About LMFA LM Funding America Inc.
LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.